Hemostatic agent use in heart and blood vessel surgery
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial surveys surgeons about how they use hemostatic agents (medications that stop bleeding during surgery). It aims to understand current practices and improve patient safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a cardiac or vascular surgeon at IRCCS Galeazzi-Sant'Ambrogio in Milan.
- You have performed heart or blood vessel surgery in the last year.
- You work at the study hospital and agree to fill out an anonymous survey.
- You are not a nurse, anesthesiologist, or other non-surgical staff.
- You are willing to answer questions about surgical cases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
This study tests a special filter (called Cytosorb) that may reduce bleeding during heart surgery by capturing the blood thinner ticagrelor from your blood. If you take ticagrelor and are scheduled for heart surgery with a bypass machine, this filter could help lower your risk of bleeding.
This study looks at how well platelets work during heart surgery using a special test called thromboelastography. It may help doctors understand and manage bleeding risks in people having planned heart surgery with a heart-lung machine.
This study looks at how blood cells change during heart surgery and whether these changes affect bleeding or inflammation after the operation. It may help doctors predict and manage complications in people having heart surgery.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
This study looks at how anesthesia, heart-lung machine use, and surgical methods are handled during heart surgery. It may help improve care for people having heart surgery.
Hear when a new Hemostasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.